Department of Management, Evaluation and Health Policy, School of Public Health, University of Montreal, Montréal, QC, Canada.
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal, CIUSSS de l'Est de l'Île de Montréal, Montréal, QC, Canada.
Int J Health Policy Manag. 2022 Feb 1;11(2):112-117. doi: 10.34172/ijhpm.2020.133.
This study evaluated the use of Cochrane systematic reviews (CSRs) by Quebec's local health technology assessment (HTA) units to promote efficiency in hospital decision-making. An online survey was conducted to examine: Characteristics of the HTA units; Knowledge about works and services from the Cochrane Collaboration; Level of satisfaction about the use of CSRs; Facilitating factors and barriers to the implementation of CSRs evidence in a local context; Suggestions to improve the use of CSRs. Data accuracy was checked by 2 independent evaluators. Ten HTA units participated. From their implementation a total of 321 HTA reports were published (49.8% included a SR). Works and services provided by the Cochrane collaboration were very well-known and HTA units were highly satisfied with CSRs (80%-100%). As regards to applicability in HTA and use of CSRs, major strengths were as follow: Useful as resource for search terms and background material; May reduce the workload (eg, brief review instead of full SR); Use to update a current review. Major weaknesses were: Limited use since no CSRs were available for many HTA projects; Difficulty to apply findings to local context; Focused only on efficacy and innocuity; Cannot be used as a substitute to a full HTA report. This study provided a unique context of assessment with a familiar group of producers, users and disseminators of CSRs in hospital setting. Since they generally used other articles from the literature or produce an original SR in complement with CSRs, this led to suggestions to improve their use of CSRs. However, the main limit for the use of CRS in local HTA will remain its lack of contextualisation. As such, this study reinforces the need to consider the notion of complementarity of experimental data informing us about causality and contextual data, allowing decision-making adapted to local issues.
本研究评估了魁北克当地卫生技术评估(HTA)机构使用 Cochrane 系统评价(CSR)来提高医院决策效率。通过在线调查,考察了以下内容:HTA 机构的特点;对 Cochrane 协作组工作和服务的了解程度;对使用 CSR 的满意度;在当地环境中实施 CSR 证据的促进因素和障碍;改进 CSR 使用的建议。数据的准确性由 2 位独立评估者进行检查。有 10 个 HTA 机构参与。从实施情况来看,共发表了 321 份 HTA 报告(49.8%包含 SR)。Cochrane 协作组提供的工作和服务非常知名,HTA 机构对 CSR 非常满意(80%-100%)。关于在 HTA 中的适用性和 CSR 的使用,主要优势如下:作为搜索词和背景材料的有用资源;可能减少工作量(例如,简短的综述而不是完整的 SR);用于更新当前的综述。主要弱点如下:由于许多 HTA 项目没有 CSR,因此使用有限;难以将发现应用于当地情况;仅关注疗效和安全性;不能替代完整的 HTA 报告。本研究提供了一个独特的评估背景,涉及到医院环境中 CSR 的熟悉生产者、使用者和传播者群体。由于他们通常使用文献中的其他文章或制作与 CSR 互补的原始 SR,因此提出了改进 CSR 使用的建议。然而,在当地 HTA 中使用 CSR 的主要限制仍然是缺乏针对性。因此,这项研究加强了需要考虑将因果关系的实验数据和适应本地问题的情境数据互补的概念。